Adlai Nortye Announces Appointment of Dr. Archie Tse as the

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, March 29, 2024 -- Adlai Nortye Ltd. , a clinical-stage biotechnology company focused on the development of innovative cancer therapies,...

Related Keywords

New York , United States , New Jersey , Memorial Sloan Kettering Cancer Center , Singapore , China , Canada , Hangzhou , Zhejiang , Amanda Kong , Adlai Nortye , Charles Zhou , Carsten Lu , Exchange Commission , Head Of Research , Nasdaq , Novartis , Adlai Nortye Ltd , Company Or Adlai Nortye , University Of Southern California , Early Clinical Development , Cstone Pharmaceuticals , Archie Tse As Head Of Research Development , Archie Tse , Molecular Biology , Chief Scientific Officer , Senior Vice President , Securities Litigation Reform Act , Markets ,